Verrica Pharmaceuticals Inc. (VRCA) Tops Q3 EPS by 21c
Tweet
Share
E-mailGet Alerts VRCA Hot Sheet
Join SI Premium – FREE
Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) reported Q3 EPS of $0.13, $0.21 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $14.3 million versus the consensus estimate of $5.34 million.
For earnings history and earnings-related data on Verrica Pharmaceuticals Inc. (VRCA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla readies August launch of CyberCab - The Information
- DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
- CACI wins U.S. Space Force contract worth up to $981M
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
